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Since the first report in 1954 outlining the
in vivo use of a double-beam spectropho-
tometer to measure the absorption of
near-infrared light by various light absorb-
ing pigments (or chromophores) involved
in the mitochondrial respiratory chain
(Chance, 1954), substantive advancements
have been made in the use of near-infrared
spectroscopy (NIRS) tomonitor the oxida-
tive state of various human tissues. Indeed,
when Chance first reported the measure-
ment of cytochrome c oxidase in yeast
cells (Chance, 1954), he likely had lit-
tle inclination that this would one day
lead to the development of the modern
day cerebral oximeter, an increasingly uti-
lized monitor aimed at optimizing patient
outcomes in a range of surgical settings.
However, it was almost 25 years later
that Jöbsis published a series of investi-
gations in animals (and in human vol-
unteers) demonstrating that blood flow
related changes in brain oxygenation could
be monitored non-invasively. These stud-
ies established that NIRS could be used
to monitor regional brain oxygen satu-
ration (rSO2) in a potentially clinically
useful manner (Jobsis, 1977). However, as
is the case with many clinical develop-
ments, it took decades of further advance-
ments before the first cerebral oxime-
ter was approved by the United States
Food and Drug Administration (Widman,
1997). Indeed, now more than 20 years
since its first approval (and 60 years after
the seminal work by Chance), we are
arguably at a cross roads in the further
development and understanding of how to
use cerebral oximetry in clinical practice.
Although substantial potential exists for
NIRS-associated advancements in patient
monitoring (and related improvements in
outcome) in a wide variety of clinical
situations, there are a number of uncer-
tainties that could prevent these devices
from reaching their full potential.
Although there are hundreds of reports
outlining numerous plausible uses for
cerebral oximetry, notably in the operat-
ing room and intensive care unit (Grocott
et al., 2010; Ghosh et al., 2012; Zheng
et al., 2013), we are still years from having
large scale, randomized controlled clini-
cal trials definitively examining the full
potential clinical benefit of this device. The
results of smaller trials, if they are to be
confidently believed, need to be replicated
and corroborated on a much larger scale.
Indeed, there are a number of reasons for
the considerable uncertainty regarding the
capability of cerebral oximeters, despite
substantive promise. Inter-device variabil-
ity, variability in oxygen saturation targets
and thresholds, issues related to abso-
lute vs. relative saturation changes, along
with studies limited by their observational
nature, have all contributed to this cur-
rent lack of confidence. Understanding the
true clinical value of this device is further
obscured by wide inter-study variability.
With respect to the variability in tech-
nology amongst the individual devices,
it is not entirely certain whether infor-
mation gained from one manufacturer’s
device can be appropriately compared
to that of another. The differences in
technology, including the choice of light
source (i.e., laser vs. light emitting diodes)
and specific wavelengths, the various pro-
prietary absorption and processing algo-
rithms, as well as the validation sequences
used, all contribute to questions of their
broader comparability (Ghosh et al.,
2012). Variability might also exist with
respect to how the devices account for
differences in skin pigmentation (Bickler
et al., 2013). Furthermore, the manner in
which these devices handle issues related
to spatial resolution could have the largest
impact on whether rSO2 measurements
are affected by extracranial contamina-
tion (Davie and Grocott, 2012). That is,
how much non-cerebral saturation signal
from the superficial tissues, contaminating
the deeper cerebral saturation signal, does
each of these devices contain? Indeed, we
recently determined, using an experimen-
tal design that allowed the separation of
scalp oxygen saturation from that of cere-
bral oxygen saturation, that the scalp con-
tamination can lead to as much as a 17%
change in the NIRS signal. Importantly,
newer generation devices were much less
prone to the contamination. Comparative
studies using more than one technology
will be needed to determine if the differ-
ences in technology are clinically relevant.
Optimizing outcome is predicated on
understanding what brain oxygen satu-
ration thresholds are worrisome enough
to clinically warrant intervention. Reports
thus far have substantive inconsistencies
as to what the optimal cerebral saturation
target should be—which leads us to the
question: what is the desaturation thresh-
old, that when crossed, increases the risk
of adverse outcomes? (Murkin et al., 2007;
Hemmerling et al., 2008; Kazan et al.,
2009; Fischer et al., 2011; Heringlake et al.,
2011; Tang et al., 2012). Specifically, is
there an absolute saturation threshold at
which there is an increased risk of adverse
clinical outcomes, such has been demon-
strated with jugular bulb desaturation in
carotid endarterectomy surgery (Moritz
et al., 2008), or is there a relative change
(from a pre-determined baseline satura-
tion) that is more important to signal
impending danger? Furthermore, if it is
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a relative change, how much of a relative
change? Defining desaturation is further
complicated by the influence of oxy-
gen supplementation on relative changes
in cerebral oxygenation. For example,
breathing 100% oxygen can elevate base-
line rSO2 and artificially widen the dif-
ference between baseline rSO2 and the
lowest rSO2 value during a surgical pro-
cedure (Bussieres et al., 2012). Finally, it
is uncertain as to whether there is a “dose
response” with respect to cerebral desatu-
ration. That is, does a brief but substan-
tial desaturation portend a worse outcome
compared to a lesser degree of desatu-
ration occurring for a more prolonged
period of time? Early data examining the
relationship between the area under the
curve for various rSO2 thresholds suggests
the latter may be the case (Fischer et al.,
2011). Whether it is an absolute or rel-
ative change in rSO2 that is important
will only be determined by analyzing both
variables in adequately sized observational
trials (see below).
The interventional algorithms used
to optimize saturation are also incom-
pletely described with respect to which of
the commonly used interventions (FiO2,
PaCO2, blood pressure, cardiac output,
hemoglobin) are considered best to opti-
mize rSO2 (Denault et al., 2007). Each
one of these interventions could conceiv-
ably improve outcome, or make it worse.
Increasing the PaCO2, blood pressure and
cardiac output could increase cerebral
blood flow while augmenting the FiO2 and
hemoglobin (with transfusion) could also
increase the oxygen content. Combined,
this would increase overall cerebral oxygen
delivery. Conversely, there is the poten-
tial for substantive morbidity related to
inappropriate transfusion, targeted hyper-
capnia and/or hypertension. For example,
erroneously increasing the PaCO2 above
the normal physiologic level in the setting
of cardiopulmonary bypass (CPB) could
lead to increases of cerebral blood flow
in excess of what is needed for cerebral
metabolism, with a subsequent increased
delivery of CPB-related air bubbles and
particulate debris. This is similar to the
use of pH-stat blood gas management,
where the addition of CO2 to the CPB
fresh gas flow (thus correcting the CO2 for
hypothermic temperature) has been asso-
ciated with worse postoperative cognitive
outcomes (Patel et al., 1996). Ultimately,
the safety of various interventional algo-
rithms will be borne out from prospective
randomized controlled trials of large size
and multi-center nature.
Arguably, one of the greatest limitations
thus far in our understanding of cerebral
oximetry has been the failure to confi-
dently delineate which clinical outcomes
have relevance to rSO2measurements.
That is, one would intuitively expect that
because it is a direct cerebral oximeter,
neurologic outcomes themselves would
have the best relationship to brain oxygen
saturation. However, a cogent argument
can easily be made regarding the biologic
plausibility that non-cerebral outcomes
could be better related to measurements
of cerebral saturation. Murkin has logi-
cally argued that the brain serves as an
“index organ” for other tissue satura-
tion (Murkin, 2011). However, the brain’s
inherent protective mechanisms (such as
metabolic and pressure related autoregu-
lation) suggest that if brain desaturation
does occur, it is likely that other tissues
have long since desaturated (Boston et al.,
2001; Grocott, 2011). That is, the brain in
effect is the last organ to be compromised,
and in some respects is not an early warn-
ing system such as a canary in the coalmine
(Grocott, 2012), but just the opposite (i.e.,
a late indicator of trouble).
Determining which endpoints to tar-
get in outcome studies employing cerebral
oximetry-guided intervention could be the
largest roadblock to the clinical progress of
cerebral oximetry. Our understanding of
how oximetry could impact patient out-
comes has been limited by the variable
endpoints outlined in multiple, but mostly
small, observational studies. These out-
comes have been so diverse that there is
considerable uncertainty as to which ones
could confidently be the focus in larger
trials. We would argue that there is still
a desperate need for a large prospective
observational trial involving at least 1000
patients, if not more (an arbitrary num-
ber, but seemingly large enough study), to
determine which outcomes may be related
to desaturation. Only then would it be pos-
sible to design a randomized controlled
trial to investigate the ability of an inter-
ventional algorithm, aimed at restoring
cerebral saturation, to modify the previ-
ously determined target outcomes. This
could also serve to delineate a potential
saturation threshold tomaintain (such as a
relative or absolute change). A good exam-
ple of this is the recent work that we
performed in a small observational study
(n = 109) in cardiac surgery (Arenson
et al., 2013). Firstly, we demonstrated
that a somewhat conservative threshold
(of an absolute saturation of less than
50%) showed a far stronger relationship
to adverse outcomes [such as acute kid-
ney injury (AKI)] than any of the relative
changes from baseline. Furthermore, and
as previously hypothesized, it was the non-
neurologic outcomes that had substantive
relationship to desaturation, with renal
dysfunction demonstrating the strongest
relationship. This is consistent with other
recent work demonstrating that when
patients were managed at low blood pres-
sures (i.e., those below cerebral autoreg-
ulatory thresholds as defined by cerebral
oximetry), they had an increased incidence
of AKI (Ono et al., 2013).
Thus, the field of cerebral oximetry
research is still relatively young and con-
tains asmany questions as it does certainty.
In order to move forward in an expedited
and confident fashion, taking advantage
of the last 60 years of research in cere-
bral NIRS, we will need to reconsider our
approach regarding further clinical devel-
opment. Otherwise, we risk wasting this
potentially valuable technology, and most
importantly, depriving our patients the
benefit of improved clinical outcomes with
its universal use.
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